Avocado/soybean unsaponifiable (ASU) to treat osteoarthritis: a clarification

Osteoarthritis and Cartilage

Volumn 16, Issue 9, 2008, Pages 1118-1119

  Henrotin, Y ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; AU NMX 1000; CHONDROITIN SULFATE; CYCLOOXYGENASE 2; DIACETYLRHEIN; GLUCOSAMINE SULFATE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIASCLEDINE; PLACEBO; PROSTAGLANDIN E2; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1;

ANTIINFLAMMATORY ACTIVITY; CARTILAGE CELL; CLINICAL TRIAL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; LETTER; MACROPHAGE; MONOCYTE; NONHUMAN; OSTEOARTHRITIS; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SYMPTOM;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; OSTEOARTHRITIS; PHYTOTHERAPY; PLANT OILS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOYBEANS;

EID: 49149101683     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.01.010     Document Type: Letter

References (11)

1. Zhang W., Doherty M., Arden N., Bannwarth B., Bijlsma J., Gunther K.P., et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64 5 (2005) 669-681
2. Jordan K.M., Arden N.K., Doherty M., Bannwarth B., Bijlsma J.W., Dieppe P., et al. EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis. Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62 12 (2003) 1145-1155
3. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 43 9 (2000) 1905-1915
4. Appelboom T., Schuermans J., Verbruggen G., Henrotin Y., and Reginster J.Y. Symptoms modifying effect of avocado/soybean unsaponifiables (ASU) in knee osteoarthritis. A double blind, prospective, placebo-controlled study. Scand J Rheumatol 30 4 (2001) 242-247
5. Maheu E., Mazieres B., Valat J.P., Loyau G., Leloet X., Bourgeois P., et al. Symptomatic efficacy of avocado/soybean unsaponifiables in the treatment of osteoarthritis of the knee and hip: a prospective, randomized, double-blind, placebo-controlled, multicenter clinical trial with a six-month treatment period and a two-month followup demonstrating a persistent effect. Arthritis Rheum 41 1 (1998) 81-91
6. Blotman F., Maheu E., Wulwik A., Caspard H., and Lopez A. Efficacy and safety of avocado/soybean unsaponifiables in the treatment of symptomatic osteoarthritis of the knee and hip. A prospective, multicenter, three-month, randomized, double-blind, placebo-controlled trial. Rev Rhum Engl Ed 64 12 (1997) 825-834
7. Henrotin Y.E., Sanchez C., Deberg M.A., Piccardi N., Guillou G.B., Msika P., et al. Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. J Rheumatol 30 8 (2003) 1825-1834
8. Henrotin Y.E., Labasse A.H., Jaspar J.M., De Groote D.D., Zheng S.X., Guillou G.B., et al. Effects of three avocado/soybean unsaponifiable mixtures on metalloproteinases, cytokines and prostaglandin E2 production by human articular chondrocytes. Clin Rheumatol 17 1 (1998) 31-39
9. Henrotin Y.E., Deberg M.A., Crielaard J.M., Piccardi N., Msika P., and Sanchez C. Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. J Rheumatol 33 8 (2006) 1668-1678
10. Au R.Y., Al-Talib T.K., Au R.Y., Phan P.V., and Frondoza C.G. Avocado soybean unsaponifiables (ASU) suppress TNF-alpha, IL-1beta, COX-2, iNOS gene expression, and prostaglandin E(2) and nitric oxide production in articular chondrocytes and monocyte/macrophages. Osteoarthritis Cartilage 15 11 (2007) 1249-1255
11. Lippiello L, Nardo JV, Harlan R, Chiou T, Metabolic effects of avocado/soy unsaponifiables on articular chondrocytes. Evid Based Complement Alternat Med (In press).